[PDF][PDF] Analyse möglicher Faktoren für die bessere Prognose p16-positiver primär operativ behandelter oropharyngealer Plattenepithelkarzinome verglichen mit p16 …
J Rauch - 2018 - edoc.ub.uni-muenchen.de
Die Malignome des Kopf-Hals-Bereiches zeigen durch dessen komplexe Embryogenese
und Anatomie eine große histologische Vielfalt. Unter den verschiedenen epithelialen …
und Anatomie eine große histologische Vielfalt. Unter den verschiedenen epithelialen …
[PDF][PDF] Nimotuzumab: beyond the EGFR signaling cascade inhibition
Author’s Accepted Manuscript Page 1 Author’s Accepted Manuscript Nimotuzumab: beyond
the EGFR signaling cascade inhibition Zaima Mazorra, Lisset Chao, Anabel Lavastida …
the EGFR signaling cascade inhibition Zaima Mazorra, Lisset Chao, Anabel Lavastida …
[PDF][PDF] EMMA-1: eine Phase-II-Studie zur Behandlung des therapierefraktären oder rezidivierten Multiplen Myeloms
DE Beschorner - 2016 - d-nb.info
EMMA-1: Eine Phase-II-Studie zur Behandlung des therapierefraktären oder rezidivierten
Multiplen Myeloms Page 1 Aus dem Zentrum für Innere Medizin der Universität zu Köln Klinik …
Multiplen Myeloms Page 1 Aus dem Zentrum für Innere Medizin der Universität zu Köln Klinik …
Identification and characterization of novel tumor-associated proteins as potential tumor markers for diagnosis and therapy
RM Grifantini - 2014 - amsdottorato.unibo.it
This study deals with the discovery and characterization of EXN6 and EXN11 as novel tumor-
associated proteins. EXN6 is mainly present in breast and ovary cancers (40 and 35%) …
associated proteins. EXN6 is mainly present in breast and ovary cancers (40 and 35%) …
[HTML][HTML] New drugs for head and neck cancer
J Dudás, H Zwierzina, GM Sprinzl - memo-Magazine of European Medical …, 2012 - Springer
Worldwide, head and neck squamous cell carcinoma (HNSCC) is the sixth most common
neoplasm, and despite advances in therapy, long-term survival in HNSCC patients is poor …
neoplasm, and despite advances in therapy, long-term survival in HNSCC patients is poor …
[PDF][PDF] The Role of the Aryl Hydrocarbon Receptor in Tumor Cell Phenotype
BC DiNatale - 2011 - etda.libraries.psu.edu
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor widely
associated with its function in xenobiotic metabolism and its ability to bind environmental …
associated with its function in xenobiotic metabolism and its ability to bind environmental …